La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Alector Gestione
Gestione criteri di controllo 2/4
Alector's Il CEO è Arnon Rosenthal, nominato in Jan2013, e ha un mandato di 11.58 anni. la retribuzione annua totale è $ 4.26M, composta da 15.4% di stipendio e 84.6% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 5.67% delle azioni della società, per un valore di $ 28.91M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.6 anni e 5.4 anni.
Informazioni chiave
Arnon Rosenthal
Amministratore delegato
US$4.3m
Compenso totale
Percentuale dello stipendio del CEO | 15.4% |
Mandato del CEO | 11.6yrs |
Proprietà del CEO | 5.7% |
Durata media del management | 2.6yrs |
Durata media del Consiglio di amministrazione | 5.4yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Alector, Inc.'s (NASDAQ:ALEC) Price Is Right But Growth Is Lacking
Jul 11Alector, Inc. (NASDAQ:ALEC) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 11Analysts Are Updating Their Alector, Inc. (NASDAQ:ALEC) Estimates After Its Full-Year Results
Mar 01The Market Doesn't Like What It Sees From Alector, Inc.'s (NASDAQ:ALEC) Revenues Yet As Shares Tumble 27%
Jan 19Alector: Good Data, Huge Cash, No Near Term Catalyst
Jan 16Here's Why We're Not Too Worried About Alector's (NASDAQ:ALEC) Cash Burn Situation
Sep 25Here's Why We're Not Too Worried About Alector's (NASDAQ:ALEC) Cash Burn Situation
Jun 27Analysts Are Betting On Alector, Inc. (NASDAQ:ALEC) With A Big Upgrade This Week
Mar 02Alector (NASDAQ:ALEC) Is In A Good Position To Deliver On Growth Plans
Jan 16Alector: Advancement Of Third Alzheimer's Drug Brings About Huge Potential
Oct 04AbbVie ends partnership with Alector for Alzheimer’s candidate
Jul 08Alector: Potential In Neurology And Cancer Treatments
Jun 14Need To Know: The Consensus Just Cut Its Alector, Inc. (NASDAQ:ALEC) Estimates For 2022
May 18Alector: Expect Phase 3 Data Next Year
Apr 16These Analysts Just Made An Downgrade To Their Alector, Inc. (NASDAQ:ALEC) EPS Forecasts
Feb 27Alector, Inc: A Newer Biotech Company With Big Potential
Jan 26Alector: The GSK Deal Is A Major Value Add
Oct 29We're Not Very Worried About Alector's (NASDAQ:ALEC) Cash Burn Rate
Sep 27This Just In: Analysts Are Boosting Their Alector, Inc. (NASDAQ:ALEC) Outlook for This Year
Aug 05Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$161m |
Mar 31 2024 | n/a | n/a | -US$121m |
Dec 31 2023 | US$4m | US$654k | -US$130m |
Sep 30 2023 | n/a | n/a | -US$141m |
Jun 30 2023 | n/a | n/a | -US$143m |
Mar 31 2023 | n/a | n/a | -US$135m |
Dec 31 2022 | US$4m | US$621k | -US$133m |
Sep 30 2022 | n/a | n/a | -US$136m |
Jun 30 2022 | n/a | n/a | US$36m |
Mar 31 2022 | n/a | n/a | -US$29m |
Dec 31 2021 | US$10m | US$575k | -US$36m |
Sep 30 2021 | n/a | n/a | -US$33m |
Jun 30 2021 | n/a | n/a | -US$212m |
Mar 31 2021 | n/a | n/a | -US$202m |
Dec 31 2020 | US$4m | US$554k | -US$190m |
Sep 30 2020 | n/a | n/a | -US$169m |
Jun 30 2020 | n/a | n/a | -US$148m |
Mar 31 2020 | n/a | n/a | -US$127m |
Dec 31 2019 | US$7m | US$525k | -US$105m |
Sep 30 2019 | n/a | n/a | -US$92m |
Jun 30 2019 | n/a | n/a | -US$76m |
Mar 31 2019 | n/a | n/a | -US$62m |
Dec 31 2018 | US$5m | US$397k | -US$52m |
Sep 30 2018 | n/a | n/a | -US$45m |
Jun 30 2018 | n/a | n/a | -US$39m |
Mar 31 2018 | n/a | n/a | -US$35m |
Dec 31 2017 | US$3m | US$370k | -US$32m |
Compensazione vs Mercato: La retribuzione totale di Arnon ($USD 4.26M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 2.44M ).
Compensazione vs guadagni: La retribuzione di Arnon è aumentata nonostante l'azienda non sia redditizia.
AMMINISTRATORE DELEGATO
Arnon Rosenthal (68 yo)
11.6yrs
Mandato
US$4,255,007
Compensazione
Dr. Arnon Rosenthal, Ph D., Co-Founded Annexon in 2013 and serves as its Chief Executive Officer and Director since 2013 and served as its President since 2013. He served as Chief Scientific Officer of Ale...
Gruppo dirigente
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Co-Founder | 11.6yrs | US$4.26m | 5.67% $ 28.9m | |
President and Head of Research & Development | 2.7yrs | US$2.61m | 0.13% $ 670.8k | |
CFO, Principal Financial Officer & Principal Accounting Officer | 2.5yrs | US$1.72m | 0.029% $ 146.4k | |
Chief Medical Officer | 2.3yrs | US$1.62m | 0.068% $ 348.5k | |
Chief Scientific Officer | 2.6yrs | Nessun dato | Nessun dato | |
Senior Director of Corporate Communication & Investor Relations | no data | Nessun dato | Nessun dato | |
General Counsel | 2.6yrs | Nessun dato | Nessun dato | |
Chief People Officer | no data | Nessun dato | Nessun dato | |
Chief Regulatory | no data | Nessun dato | Nessun dato | |
Chief of Staff & Head of Strategy | 2.6yrs | Nessun dato | Nessun dato | |
Senior Vice President of Portfolio & Program Management | 2.6yrs | Nessun dato | Nessun dato | |
Chief Business Officer | less than a year | Nessun dato | Nessun dato |
2.6yrs
Durata media
56yo
Età media
Gestione esperta: Il team dirigenziale di ALEC è considerato esperto (durata media dell'incarico 2.6 anni).
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Co-Founder | 11.6yrs | US$4.26m | 5.67% $ 28.9m | |
Independent Chairperson of the Board | 5.8yrs | US$355.07k | 0.037% $ 187.1k | |
Director & Member of Scientific Advisory Board | 5.8yrs | US$509.13k | 0.045% $ 231.9k | |
Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Independent Director | 5.8yrs | US$324.71k | 0.083% $ 420.9k | |
Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Independent Director | 4.4yrs | US$318.92k | 0.026% $ 132.1k | |
Independent Director | 5yrs | US$318.12k | 0.034% $ 171.4k | |
Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Member of Scientific Advisory Board | 2.6yrs | Nessun dato | Nessun dato | |
Independent Director | 2.9yrs | US$322.27k | 0.027% $ 137.5k |
5.4yrs
Durata media
67yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di ALEC sono considerati esperti (durata media dell'incarico 5.4 anni).